2.73MUSD
3.29
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US98979H3012
CUSIP
98979H103
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
2.87
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
-15.686
Wall Street Target Price
21.00
EPS Estimate Current Year
-0.09
EPS Estimate Next Year
-0.09
EPS Estimate Current Quarter
-1.75
EPS Estimate Next Quarter
-0.02
Most Recent Quarter
-
Revenue TTM
659,000
Gross Profit TTM
-20,985,000
EBITDA
-29,295,000
Profit Margin
0.00%
Return On Assets TTM
-41.86%
Return On Equity TTM
-192.97%
Revenue Per Share TTM
0.187
Qtly Revenue Growth YOY
-48.80%
Diluted Eps TTM
-15.686
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
4.148
Price Book MRQ
0.157
Enterprise Value Revenue
4
Enterprise Value EBITDA
0
556.74
2.05%465.79
1.61%31.43
1.49%109.62
0.65%90.00
0.00%182.50
0.00%161.72
0.00%83.82
0.00%3.63
0.00%64.51
-0.11%